|
IPO8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.05289945837728E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.92090004908141E-09 |
| Normal-vs-Stage2 |
2.882500E-03 |
| Normal-vs-Stage3 |
1.66884999999173E-05 |
| Normal-vs-Stage4 |
5.028100E-02 |
| Stage1-vs-Stage2 |
8.728800E-01 |
| Stage1-vs-Stage3 |
5.272000E-01 |
| Stage1-vs-Stage4 |
7.863600E-01 |
| Stage2-vs-Stage3 |
5.263000E-01 |
| Stage2-vs-Stage4 |
7.548400E-01 |
| Stage3-vs-Stage4 |
9.093800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52269974407204E-10 |
| Normal-vs-AfricanAmerican |
6.184400E-04 |
| Normal-vs-Asian |
7.78399999999957E-05 |
| Caucasian-vs-AfricanAmerican |
8.679600E-02 |
| Caucasian-vs-Asian |
5.586600E-01 |
| AfricanAmerican-vs-Asian |
2.562600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.25909957407566E-10 |
| Normal-vs-Female |
5.55449999999347E-05 |
| Male-vs-Female |
1.471030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.83030000044937E-07 |
| Normal-vs-Extreme_Weight |
2.28099983345942E-10 |
| Normal-vs-Obese |
8.24780000000525E-05 |
| Normal-vs-Extreme_Obese |
3.976600E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.039400E-01 |
| Normal_Weight-vs-Obese |
1.154240E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.030000E-01 |
| Extreme_Weight-vs-Obese |
4.985800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.564800E-01 |
| Obese-vs-Extreme_Obese |
2.955000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.375500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.5540699999983E-05 |
| Normal-vs-Age(61-80Yrs) |
4.24390522724138E-11 |
| Normal-vs-Age(81-100Yrs) |
5.03570000032205E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.283800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.182200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.632000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.053800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.323020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.993400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.01190000045825E-07 |
| Normal-VS-Type2 PRCC |
8.25717272334714E-12 |
| Normal-VS-KIRP CIMP |
2.04159999999121E-05 |
| Normal-VS-Unclassified PRCC |
7.455800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.217200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.669800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.029000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.276600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.555800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.294410E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.91630000335419E-10 |
| Normal-vs-N1 |
4.838600E-03 |
| Normal-vs-N2 |
1.563190E-03 |
| N0-vs-N1 |
2.626200E-01 |
| N0-vs-N2 |
7.370400E-01 |
| N1-vs-N2 |
6.644200E-01 |
|
|
